AU Patent

AU2012202307B2 — Muscarinic acetylcholine receptor antagonists

Assigned to Glaxo Group Ltd · Expires 2015-05-07 · 11y expired

What this patent protects

C:\NRPornb\DCC\SXDWZ75955_. DOC-19A4/202 Muscarinic Acetylcholine Receptor Antagonists and methods of using them are provided.

USPTO Abstract

C:\NRPornb\DCC\SXDWZ75955_. DOC-19A4/202 Muscarinic Acetylcholine Receptor Antagonists and methods of using them are provided.

Drugs covered by this patent

Patent Metadata

Patent number
AU2012202307B2
Jurisdiction
AU
Classification
—
Expires
2015-05-07
Drug substance claim
No
Drug product claim
No
Assignee
Glaxo Group Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.